Literature DB >> 30231042

Development of a complex intervention for early integration of palliative home care into standard care for end-stage COPD patients: A Phase 0-I study.

Charlotte Scheerens1,2, Kenneth Chambaere1,2, Koen Pardon1, Eric Derom2,3, Simon Van Belle1,4, Guy Joos2,3, Peter Pype1,5, Luc Deliens1,2.   

Abstract

BACKGROUND: Research suggests that palliative home care should be integrated early into standard care for end-stage COPD patients. Patients also express the wish to be cared for and to die at home. However, a practice model for early integration of palliative home care (PHC) into standard care for end-stage COPD has not been fully developed. AIM: To develop an intervention for early integration of PHC into standard care for end-stage COPD patients.
METHODS: We conducted a Phase 0-I study according to the Medical Research Council Framework for the development of complex interventions. Phase 0 aimed to identify the inclusion criteria and key components of the intervention by way of an explorative literature search of interventions, expert consultations, and seven focus groups with general practitioners and community nurses on perceived barriers to and facilitators of early integrated PHC for COPD. In Phase 1, the intervention, its inclusion criteria and its components were developed and further refined by an expert panel and two expert opinions.
RESULTS: Phase 0 resulted in identification of inclusion criteria and components from existing interventions, and barriers to and facilitators of early integration of PHC for end-stage COPD. Based on these findings, a nurse-led intervention was developed in Phase I consisting of training for PHC nurses in symptom recognition and physical therapy exercises for end-stage COPD, regular visits by PHC nurses at the patients' homes, two information leaflets on self-management, a semi-structured protocol and follow-up plan to record the outcomes of the home visits, and integration of care by enabling collaboration and communication between home and hospital-based professional caregivers.
CONCLUSION: This Phase 0-I trial succeeded in developing a complex intervention for early integration of PHC for end-stage COPD. The use of three methods in Phase 0 gave reliable data on which to base inclusion criteria and components of the intervention. The preliminary effectiveness, feasibility and acceptability of the intervention will be subsequently tested in a Phase II study.

Entities:  

Mesh:

Year:  2018        PMID: 30231042      PMCID: PMC6145576          DOI: 10.1371/journal.pone.0203326

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Background

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death[1] and involves a progressive, inexorable functional decline and acute episodes of exacerbation[2]. End-stage COPD patients display symptoms including dyspnea, fatigue, anxiety and low mood, leading to a reduced quality of life[3]. Even with medical care, these symptoms impact heavily on daily activities, emotional and social functioning[3] while physical and psychosocial needs are inadequately addressed[4]. Integrating palliative care (PC) early into regular care could address these unmet needs and could have a positive impact on end-stage COPD patients[5,6]. Conversations about prognosis should be an integral part of care; strategies for professional caregivers to facilitate these discussions include being aware of the implications of the diagnosis, building a good relationship with the patient and starting the discussion of prognosis early in the disease course[7]. While patients with end-stage COPD often die in intensive care unit settings in hospital rather than at home[8], they actually prefer to be cared for at home[9] and to die at home[10]. If PC was provided at home it could improve quality of life[11,12], and increase the chances of dying at home[13]. Moreover, if palliative home care (PHC) was provided early enough it could avoid unnecessary hospital visits and admissions, overly aggressive care and excessive end-of-life-related medical costs[14]. Patients with end-stage COPD themselves express the need for integrated PHC as an addition to standard care[15]. However, implementing PHC early is not without its challenges because the unpredictability of the illness trajectory and survival time can complicate decisions about when to introduce it[5]. There are other challenges e.g. that some professional caregivers view PC for end-stage COPD as not valuable or believe that PC needs can be addressed by standard care alone[16]. Furthermore, research on implementing and testing early integrated PHC in clinical practice for end-stage COPD is fairly limited, with studies focusing either on PHC or on early PC, but not on both, except for one trial that tested acceptance of home support and integrated care among end-stage COPD patients[15]. Other studies and trials explored place of death and costs of medical care for COPD patients receiving PHC[13], early introduction of specialised PC for COPD[17,18], management of mainly one symptom i.e. breathlessness through PHC[19] or identification tools for end-stage COPD patients in need of proactive PC[20]. Interventions in cancer research have also tested some models of early and/or integrated PC/PHC demonstrating positive effects on quality of life and quality of care[21-25]. However, a practical model to implement early integration of PHC in standard home care for end-stage COPD patients is lacking; therefore, our study aim was to develop an evidence-based intervention supporting the early integration of PHC into standard care for end-stage COPD patients.

Methods

Study design

The intervention was developed using the Medical Research Council (MRC) framework for complex intervention design[26]. This framework provides multiples steps (from Phase 0 to Phase IV) for developing and evaluating complex interventions. The process may take different forms, with several Phases consisting of key functions and activities. The arrows indicate the main interactions between the Phases (Fig 1). Reporting is not shown as a separate activity, because it is regarded as an important element of each stage in the process[26]. This study consists of a Phase 0-I trial involving the identification and modelling of the inclusion criteria, core components of the intervention.
Fig 1

Medical Research Council framework for development and evaluation of complex interventions.

Phase 0 –Identifying the evidence base and developing the theory

Three methods were used to obtain data for developing inclusion criteria and key components. Key components—the core of the intervention—are intended to be, and have been, positively associated with the outcomes that address identified needs[27,28]. The first method was an exploration of relevant literature, taking place between April 2015 and November 2016. This search identified published trial results and protocol papers of uncompleted trials on PC and/or symptom management for COPD. The used methodology was an explorative literature search. A search strategy was developed by CS and KC for PubMed. A combination of controlled vocabulary and free text words was used to search in titles and abstracts: COPD and intervention in combination with PC, early PC, general practitioners (GPs), and symptom management. The reference list of all identified studies was screened for additional relevant studies. A study was included if it reported: (1) Intervention results or an intervention protocol (the most recent results of one trial needed to be included), (2) Components related to PC or symptom management for end-stage COPD patients, and (3) Clear reference to inclusion criteria of participants. The eligibility of selected studies was independently assessed by CS and KC, and this selection was then revised by the research team. Appraisal was undertaken by CS and KC by critically reviewing all selected studies. No appraisal tool was used as the design was exploratory and not systematically. The second method, undertaken between May and September 2016, was to consult experts for their views on possible inclusion criteria and components, based on their experiences and ideas about the future of PHC. 27 national and international experts from either clinical and/or research settings were selected for their research and/or clinical expertise in PC and/or COPD as a criterion. An extra criterion was stipulated for Belgian experts, namely their knowledge about the Belgian and Flemish healthcare context concerning care for COPD, as this was information we could not gather from the literature search and from international experts. By recruiting both experts in PC and/or in COPD we tried to obtain a sample of experts representing a wide range of experience related to the topic (maximum variation sampling). Other international and national experts in COPD and/or PC were recruited through professional contacts of experts we interviewed (snowball sampling). A topic guide in English and in Dutch can be seen in S1 Table. Thirdly, we conducted focus groups between September 2015 and September 2016 to gain more insight into PHC practices, current standard care, barriers to be overcome and facilitators to promote early integration of PHC for end-stage COPD patients in Flanders, Belgium. This method complemented the previous methods with information about the specific Flemish context of the intervention. The methods of the focus groups are published elsewhere[29].

Phase I: Modelling the intervention for clinical practice

In Phase I, the intervention was modelled[30]. Outcomes of the intervention were stipulated to be improvement in quality of life for end-stage COPD patients and in quality of care. The research team developed a first draft of a complex intervention, based on the results of Phase 0. The most common used and mentioned inclusion criteria and intervention components were selected, while also taking into account the research setting, the Flemish context, possibilities to replicate the intervention, feasibility and acceptability issues. Refinements to this draft were done by one expert panel and two individual expert opinions who further selected the best courses of action in order to enhance implementation. These Flemish experts identified possible implementation barriers which could occur and searched for solutions to overcome these barriers.

Flemish expert panel and expert opinions for implementation issues

The Flemish experts were selected for knowledge about COPD, either in clinical practice, in PHC or in social work. The expert panel and expert opinions were held in December 2016, of which the panel took one and a half hour, was audio taped and transcribed verbatim, while the expert opinions were via e-mail. The expert panel (n = 8) consisted of three GPs, a pulmonologist, a pulmonary nurse, a community nurse (CN) and a psychologist who works in a PHC team. Some of them had also been consulted for Phase 0 in the expert consultations or the focus groups. The two expert opinions were provided by a GP and a social worker. They all went through the draft of the intervention for improvements and adaptations. The inclusion criteria were also revised on implementation issues by a well-experienced pulmonologist. The obtained data were categorised for each inclusion criterion and component and analysed within the research team to finalise the intervention. A flow diagram of the methods used from Phase 0 to I is given in Table 1.
Table 1

Use of the theory and modelling Phase from the Medical Research Council framework.

DefinitionSteps undertaken
(1) Phase 0 –theory
(1.1) Identifying the evidence base by carrying out an explorative literature search(i) Reviewed existing interventions on palliative care and symptom management for end-stage COPD patients on their design, components, inclusion criteria, and results on outcomes.(ii) Reviewed existing intervention protocols on palliative care and symptom management for end-stage COPD patients on their design, components, inclusion criteria, and chosen outcomes.
(1.2) Identifying international and national insights on possible inclusion criteria and core components by carrying out expert consultations(i) Interviewed 21 experts on their view about successful interventions for early integration of palliative home care for end-stage COPD, based on the inclusion criteria and components we identified in the explorative literature search, and on other components the experts identified during the consultations.
(1.3) Identifying insights on the Flemish context of early integrated palliative home care for end-stage COPD, which could not be derived from 1.1 and 1.2(i) Conducted three focus group conversations with general practitioners and four with community nurses on barriers and facilitators for early integration of palliative home care for end-stage COPD patients in Flanders.
(2) Phase I–modelling the intervention
(2.1) Selecting inclusion criteria by using a pragmatic approach based on the critical consideration of the research team, using the results from Phase 0 and taking into account the Flemish clinical practice context, the research setting, feasibility and acceptability issues(i) Linked all results on inclusion criteria from the different methods in Phase 0 and analysedreisbu them.(ii) Selected the most common used or positively mentioned inclusion criteria from both literature and expert consultations.(iii) Sorted the inclusion criteria on their relevance for the intervention, taking into account the Flemish clinical practice and palliative home care context by also consulting the obtained results from the focus groups on the facilitator: trigger moments.
(2.2) Selecting intervention components by using a pragmatic approach based on the critical consideration of the research team, using the results from Phase 0 and taking into account the Flemish clinical practice context, the research setting, feasibility and acceptability issues, and possibilities for replicating it. Outcomes of the intervention should be improvement of quality of life for end-stage COPD patients and quality of care.(i) Linked all results on key components from all methods used in Phase 0 and compared the results.(ii) Identified the most common used or positively mentioned components from both literature and expert consultations.(iii) Compared the most common used or positively mentioned components from the literature search and the expert consultations and sorted them on their relevance for the intervention. This was done by taking into account their applicability in the Flemish context as we reviewed the identified barriers and facilitators from the focus group study in relation to these components. (iiii) Selected and designed five key components in a first draft of the intervention, using combinations of components from previous interventions, material from previous projects for COPD and new developed components by the research team members themselves.
(2.3) Identifying implementation issues concerning the chosen inclusion criteria and components specific for the Flemish context(i) Reviewed the most common inclusion and exclusion criteria identified in Phase 0 by a pulmonologist with long experience in clinical practice for end-stage COPD on implementation issues and feasibility and adapted several criteria for better implementation chances.(ii) Consulted the involved palliative home care team on feasibility and acceptability issues of the selected components.(iii) Consulted an expert panel and two expert opinions on their views, comments and suggestions of the first draft of the intervention, focusing on implementation, feasibility and acceptability issues.
(2.4) Finalising the intervention modelThe research team analysed the obtained remarks from the pulmonologist, involved palliative home care team, expert panel and expert opinions and adjusted the intervention’s inclusion criteria and components in a final draft.

Ethical aspects

The research protocol and topic guides for the focus groups were approved by the Ethics Committee of Ghent University Hospital (Reference: 2016/0171).A signed informed consent was obtained from each participant in the focus groups and the expert consultations, panel and opinions. Anonymity was assured by preventing the participants being identified from the transcripts.

Results

Phase 0 –Identifying the evidence base and developing theory

Exploration of relevant literature

From the explorative electronic database search 68 records were identified. After removal of duplicates and irrelevant reports, the title and abstract of 58 records was screened and 30 full-text articles were retrieved for detailed evaluation. Contact with the first authors and a search in reference lists of included articles yielded eight records. Seventeen articles met all inclusion criteria and were included for data-extraction and quality assessment (Fig 2). Eleven were intervention studies and six were intervention protocols.
Fig 2

Full electronic search strategy.

The most commonly used inclusion criteria in the studies were hospitalisation for an exacerbation (recently, one or more times in the last year), end-stage dyspnea (according to the Medical Research Council Dyspnea score) and lung function scores (mostly GOLD III/IV) (Table 2).
Table 2

Inclusion criteria of interventions and intervention protocols on palliative care and symptom management for end-stage COPD patients based on explorative literature search.

Inclusion criteriaUsed x times in explored studies
Hospitalisation for an exacerbation (recently OR 1–2 times in last year(s))10
End-stage dyspnea (Medial Research Council dyspnea Scale score 5)5
End-stage COPD (mostly GOLD III/IV)5
FEV1 (airflow limited)3
Age3
Smoking habits (ex-smoker or intending to quit/current or former smoker)3
Hypercapnia/hypoxemia2
BMI (<21)2
Free of exacerbation last month2
Housebound1
Inhalation therapy1
Domiciliary oxygen/ home ventilation1
Surprise question (will die within one year or readmission within 8 weeks)1
Comorbidity1
Hospital Anxiety and Depression Scale score > = 81
Visit for pulmonary follow-up1
The most used key components in the analysed studies were (1) advance care planning: training GPs[31] and respiratory nurses[32], or testing whether advance care planning affected the end-stage COPD patient’s decision-making about future preferences[33]; (2) respiratory rehabilitation: simple home and intensive hospital-based pulmonary rehabilitation programmes[34], the involvement of respiratory health workers[35] or the integration of respiratory services with standard care therapy[6]; (3) specialised PC: specialised PC added to standard care[18,20]; (4) training professional caregivers: training GPs in early identification of end-stage COPD patients in need of PC, training on communication about preferences and written advance directives[31] or training on inhalation techniques[36]; (5) educating end-stage COPD patients: educating end-stage COPD patients about identification and treatment of exacerbations[37], decision-making in end-of-life care[38] or cognitive restructuring where patients learn to interpret physical and psychological symptoms about anxiety and dyspnea[39], and (6) improving self-management of end-stage COPD patients: using telemonitoring for symptom reporting[40], developing a breathlessness service for managing breathlessness[19,41] or using an action plan with a holistic assessment of physical, psychological, social and spiritual/existential needs[42]. A broader overview of the key components derived from the explorative literature search can be seen in S2 Table, and in-detail examination of it in S3 Table.

Expert consultations

Of the 27 experts invited for consultation, 21 accepted the invitation. Nine were from Belgium, of whom six had expertise in PC and three in COPD. Twelve were from other countries, of whom seven were PC experts, two were experts in COPD, and three were experts in both PC and COPD. Experts were pulmonary specialists, a physiotherapist, experienced researchers, policymakers, people working in a PHC unit and GPs. (Table 3).
Table 3

Characteristics of consulted experts.

Expert numberProfessionCountryExpertise
1Palliative home care head nurseCoordinator palliative home care teamBelgiumPalliative care
2Palliative home care nurseBelgiumPalliative care
3General practitionerPalliative home care physicianScientific researcherBelgiumPalliative care
4General practitioner Scientific researcherBelgiumPalliative care
5General practitionerScientific researcherBelgiumCOPD
6General practitionerScientific researcherBelgiumPalliative care
7Pulmonary physicianScientific researcherBelgiumCOPD
8Pulmonary physiotherapistBelgiumCOPD
9Respiratory physicianScientific researcherSwitzerlandPalliative careCOPD
10General practitionerPalliative home care physicianBelgiumPalliative care
11Respiratory physicianScientific researcherAustraliaCOPD
12Respiratory physicianAustraliaPalliative careCOPD
13Respiratory physicianScientific researcherSpainPalliative care
14Palliative care physicianScientific researcherSpainPalliative care
15Researcher social sciencesGermanyPalliative care
16Palliative care physicianResearcher medical scienceCanadaPalliative care
17Member of a Scientific InstituteProfessor in medicineUnited KingdomPalliative care
18Member of an expertise centre in Palliative CareResearcher in pain and palliative medicineNetherlandsPalliative care
19Scientific researcherNetherlandsPalliative care
20Scientific researcherUnited KingdomPalliative careCOPD
21Respiratory and sleep physicianAustraliaCOPD
The experts considered inclusion and exclusion criteria by suggesting which criterion indicated PHC needs, and which not. They mentioned positive (facilitators) and negative (barriers) comments for each criterion. The most common mentioned inclusion criteria were: after admission in hospital for exacerbation (eight experts in favor), depending on lung function test (eight in favor, but also six not in favor), depending of functioning of the patient (four in favor) and being housebound (three in favor) (Table 4).
Table 4

Summary of possible inclusion criteria and components for early integration of palliative home care according to expert consultations.

Inclusion criteriaFacilitators mentioned by experts*Barriers mentioned by experts*
ABCDETotalABCDETotal
After admission in hospital for exacerbation12, 2214, 16, 17, 19, 202184222
Functioning of the patient2214, 161040
Depending on lung function test412, 2214, 15, 16, 18, 1989415, 16, 19, 206
Depending of social context0161
Opinion of caregiver710
Being housebound1214, 163221
Oxygen dependency12, 2220
ComponentFacilitators mentioned by experts*Barriers mentioned by experts*
ABCDETotalABCDETotal
Advance Care Planning51, 2, 3, 4, 1112, 2215, 17, 18, 19, 20131453, 1112, 2215, 2013, 219
Involvement of informal caregivers912, 2215, 16216922163
Knowledge and disease-insight91, 2, 112215, 17, 1810915102
Pulmonary rehabilitation91, 2, 3, 42217, 18219917, 18214
Psychosocial support51, 2, 614, 15, 16, 17, 1810, 2111314, 15, 164
Self-management1, 22215, 17, 1810, 21815, 162
Symptom control1, 2, 3, 4, 111215, 17, 1810, 21110

*The results are presented in following order: A: Belgian experts in COPD; B: Belgian experts in palliative care; C: Foreign experts in COPD; D: Foreign experts in palliative care;

E: Foreign experts in COPD and palliative care. The numbers in these boxes (with exception of the total numbers) represent the experts’ numbers from Table 3.

Possible components were discussed: advance care planning, psychosocial support and symptom control were recommended respectively by fourteen, eleven and eleven experts, although advance care planning was also seen as less suitable by nine and the benefits of psychosocial support were questioned by four. Increasing the patient’s knowledge and disease insight and providing pulmonary rehabilitation were each recommended by nine experts but barriers were also mentioned by respectively two and four. Eight experts stressed the importance of incorporating self-management into the intervention, while two reported barriers to that. Lastly, six experts saw possibilities for the involvement of informal caregivers in a PHC intervention, and three questioned it (Table 4). S4 Table provides an in-detail description of the mentioned barriers and facilitators for inclusion criteria and components. *The results are presented in following order: A: Belgian experts in COPD; B: Belgian experts in palliative care; C: Foreign experts in COPD; D: Foreign experts in palliative care; E: Foreign experts in COPD and palliative care. The numbers in these boxes (with exception of the total numbers) represent the experts’ numbers from Table 3.

Focus groups

Three focus groups with GPs (n = 8, n = 8, n = 10) and four with CNs (n = 4, n = 7, n = 5, n = 12) were held. The categories of barriers related to early integration of PHC were (1) Unpredictable exacerbations and death in COPD and invisible deterioration of functioning; (2) Perceived patient attitudes such as a lack of disease insight and resistance towards care; (3) Professional caregiver practices with a lack of a coherent and proactive plan, insufficient experience and a negative view of PHC for end-stage COPD; (4) Not enough focus on knowledge and advantages of PHC and PC for end-stage COPD in professional caregivers’ basic and continuing education; (5) Healthcare and PHC system characteristics: too short consultations, insufficient coordination between hospital and home care, and a reimbursement system for PHC that is based on life expectancy; and (6) Communication: a lack of and unclear communication between professional caregivers about further care possibilities for end-stage COPD patients, and a lack of clear information about PHC between professional caregivers and their patients. The categories of facilitators were (1) Trigger moments to start talking about early integration of PHC such as after hospitalisation, after a couple of exacerbations, when an end-stage COPD patient becomes oxygen-dependent or becomes housebound; (2) Involvement of informal caregivers in early integrated PHC for COPD; (3) Information about the advantages of early integrated PHC for end-stage COPD in professional caregivers’ education; (4) Including advance care planning as a part of healthcare and PHC systems and (5) Communication: enhancing communication between professional caregivers by installing a care coordinator, and between professional caregivers and end-stage COPD patients by explaining better and in a practical way early integrated PHC. The elaborate results are published elsewhere[29].

Phase I: Modelling process and outcomes

Inclusion criteria

The most common used or mentioned inclusion criteria from literature and expert consultations were cross referenced to Flemish and clinical implementation issues. Lung function tests (GOLD III and GOLD IV[43]) were selected as a basic inclusion criterion to identify the end-stage of COPD. Next, as recommendations from GOLD[43] and the results in Phase 0 also stipulated that lowering of functioning and frequent exacerbations are evenly important predictors of end-stage COPD, we decided to combine lung function tests with two (in case of GOLD III) or one (in case of GOLD IV) criteria/criterion representing frequent and severe exacerbations (three or more hospitalisations for COPD in the past three years) or lowering of functioning (oxygen-dependent, COPD Assessment Test-scale ≥25, Medical Research Council dyspnea-scale of 4, intubation or non-invasive ventilation in the past year, low Body Mass Index or heart failure New York Heart Association of 3). By designing the criteria in this way, we tried to incorporate the diverse ways end-stage COPD could occur. The selected exclusion criteria reflect a patient able to participate in the study such as region of residence, Dutch speaking and no or low cognitive impairment. We also excluded active cancers as patients would otherwise have a higher chance of referral to PHC because of their cancer diagnosis (Table 5).
Table 5

Final selection of inclusion and exclusion criteria.

Inclusion criteriaExclusion criteria
GOLD III (cf. GOLD 2017[43]) and ≥ 2 of following criteria OR GOLD IV (cf. GOLD 2017[43]) and ≥1 of following criteria:➢ Oxygen-dependent[44]➢ Three or more hospitalisations for COPD in the past three years➢ COPD Assessment Test -scale ≥25[43]➢ Medical Research Council Scale Dyspnea 4➢ Intubation in the past year➢ Non-invasive ventilation in the past year➢ Body Mass Index ≤18➢ New York Hart Association- scale of 3Patients living outside the region Ghent-Eeklo, Flanders, Belgium (where the intervention will take place)Patients in the last days of life (bedbound and/or semi-comatose and/or take only fluid and/or no longer able to take oral drugs[18])Patients with cognitive impairment: Mini Mental status Examination ≤23 at the day of inclusion of patients[45]Lung cancer diagnosisPatients with active cancerPatients who are not living at home any morePatients with no knowledge of DutchPatients with a general practitioner already involved in this study for an intervention/control group patient

Components

The five final components were developed by combining all results from Phase 0. Predefined outcomes for the intervention were improving quality of life for end-stage COPD patients and quality of care. Therefore, we prioritised the most common used or mentioned components from the literature and expert consultations: advance care planning, pulmonary rehabilitation, patients’ knowledge and disease-insight and symptom control. The results also suggested to include the involvement of informal caregivers, psychosocial support and self-management as a component. Furthermore, the results from the focus group study revealed that advance care planning, training professional caregivers, increasing knowledge about COPD and PHC for patients and involving informal caregivers could enhance early integrated PHC. Almost all these components were included in the first draft of the design, representing a holistic PHC approach[42]. However, the final selection of components took into account the Flemish context of PHC, feasibility issues for the involved PHC team and for the research setting, replication possibilities for other studies and implementation issues in clinical practice. Pulmonary rehabilitation was therefore excluded as a component on its own, as this was not feasible for the involved PHC team of the intervention. Also, advance care planning and involving informal caregivers were combined in one component. As PHC teams in Flanders already offer advance care planning and support for informal caregivers as standard PHC, we chose to focus the component more on a systematic reporting tool about these subjects, as this still lacking in their current care management. After the content of the intervention was decided, we modelled and further operationalised it into five concrete components using elements from previous interventions and projects as well new ideas from the research team. Further adjustments were made by the expert panel and expert opinions. The components are: (1) Training of the PHC team in care for end-stage COPD patients, (2) Monthly home visits by a PHC nurse, (3) Information leaflets, (4) A semi-structured protocol for home visits, and (5) Integration of care between involved professional caregivers. Component 1—Training of the PHC team in care for end-stage COPD patients: Training in knowledge and care for patients with end-stage COPD will be provided to the nurses of the PHC team, who expressed the need for this. The PHC team will also learn to work with the semi-structured protocol and the information leaflets. The expert panel confirmed the need for training the team and agreed on the topics (see infra) included in the training. One expert advised the inclusion of information on the value of physical activity and dietary advice as many end-stage COPD patients suffer from nutritional deficiencies and low muscle mass. The research team decided to include this recommendation. The topics of training will be: - Providing information on the disease trajectory of COPD and the symptom burden for end-stage COPD patients - Recognising and managing an exacerbation - Providing information about the role of exercise, breathing exercises, coping with the disease and self-management skills - Learning to work with the semi-structured protocol that will be used during home visits - Learning to work with the information leaflets ‘Breathing and saving energy’ and ‘Preventing and coping with complaints’ Component 2—Home visits by a PHC nurse: Home visits by a PHC nurse are already part of PHC as usual to support the patient and their informal caregivers. However, end-stage COPD patients are not receiving PHC visits systematically in Flanders and if so, it is mainly in the terminal phase[46]. In Phase 0, it became clear from the literature[47] that end-stage COPD patients need more systematic support for their symptoms and concerns, and not only in the terminal phase. Therefore, systematic home visits by a PHC nurse are incorporated as a component with a minimum frequency of one per month over a period of six months in total, which can be increased if more follow-up would be needed. This was seen as appropriate by the expert panel. Component 3—Information leaflets: In current PHC practice in Flanders, tools for patients’ self-management, knowledge and disease insight are insufficiently used, although this could vary among PHC teams. In contrast, both the literature[19,41] and our expert consultations provided evidence for the benefits of appending self-management tools in PHC for end-stage COPD patients. Therefore, information leaflets on self-management of COPD symptoms were selected as an component. The leaflets will be offered to the patient during PHC visits. The expert panel recommended that Flemish leaflets should be used to improve comprehensibility for Flemish people, but as there were none in existence at the time, Dutch-translated leaflets from the ‘Living well with COPD’ Canadian project, originally developed in English, were chosen[48]. This project is a Canadian learning method for COPD patients and their families. It focuses on raising awareness and knowledge about COPD and on teaching patients possible coping mechanisms, breathing exercises, knowledge and use of medication. The Dutch-translated leaflets were developed for patients living in the Netherlands and contain therefore information e.g. brand names of medication only available in the Netherlands. Following the expert panel’s advise, we replaced this with a list of medication available in Belgium. Also, some words used in the Dutch-translated leaflets are not used in Flemish, but as we considered the general content very clear for Flemish speaking patients, this was left unchanged. However, we will analyse this possible bias in the feasibility and acceptability study from the Phase II intervention. Component 4 –Semi-structured protocol during home visits: Currently, most PHC teams in Flanders do not use a standardised registration document listing and reporting all possible topics of care and support covered during home visits. PHC nurses also lack knowledge about the specific symptom burden in end-stage COPD. We therefore developed a semi-structured protocol for reporting about a pre-defined list of COPD-related care and support management topics during home visits. The structure of the protocol is inspired by the interventions of Weber et al[17], Buckingham et al[42] and Vanbutsele et al[23] and contains nine focus areas, representing a holistic PHC approach: disease-insight and coping, symptom management (flagged by completing The Dutch version of the Edmonton Symptom Assessment Scale (ESAS)), care planning, support for informal caregivers, psychosocial support, spiritual support, other non-predefined support e.g. financial, practical and administrative, coordination of care and an action plan (Table 6). The expert panel recommended changing some words from the Dutch ESAS into Flemish in order to improve interpretation. They also added ‘tightness in the chest’ next to ‘breathlessness’ as the former referred to another symptom than the latter.
Table 6

Focus areas in the semi-structured protocol for the palliative home care nurse.

Focus areaExplanation
Disease insight and copingAnamnesis of the disease and the patientListening to the patient’s experience of his/her dyspneaInformation about dyspnea and COPD (through conversation and info-leaflets) and medication (if needed)
Symptom managementStandard care package of the palliative home care teamAssessment of symptoms (ESAS)
Care planningValues and wishes of the patient for the futurePreferences for end-of-life care (for example about hospitalisations)Living will/advance directive
Support for those close to the person who is dying (if needed)Identification of those closest to the personAssessment of their needsProviding available resources if needed
Psychosocial supportAssessment of needs (psychological, social, financial, administrative, activities of daily living)Providing available resources if neededIf needed, referral to other professional caregivers or social workers if patients agrees
Spiritual/existential supportAssessment of needs (how he/she see the future, who he/she get existential/spiritual support from, if there are particular worries)Providing available support
Other supportAssessment of other concerns or needs (for example: practical needs related to housing)Follow-up of problems if help can be given
Coordination of careListing all involved professional caregivers, their function, treatment goals and interventionsInvolving professional caregivers in the follow-up of the patient and their vision on further careCommunication about coordination of care with the involved general practitioner
Action planListing agreed actions the patient can undertake to tackle certain problems, identified in one or more of the other focus areasPatient, general practitioner, community nurse, physiotherapist and pulmonologist receive an overview of these actions after each visit
Component 5 –Integration of care between involved professional caregivers: Current PHC in Flanders does not use standard reporting or communication procedures between PHC nurses and other professional caregivers, except for regular contact with the GP, who instigates PHC. As seen in Phase 0, the focus groups stressed the need for a care coordinator to install a proactive care plan as conflicting treatment between professional caregivers often occurs. Consequently, the component ‘integration of care’ will systematise report mechanisms and communication between the PHC nurses and involved professional caregivers. With the agreement of the patient, the PHC nurse will send a report of the semi-structured protocol with the action plan and the overview of the coordination after each home visit to the GP, CN, physiotherapist and pulmonologist. The GPs will be particularly involved as the PHC nurse will always contact them if further action or care is needed and if important changes in the health status of the patient would occur. An overview of how the final components were derived from the Phase 0 results can be seen in Table 7.
Table 7

Describing components of an intervention to integrate palliative home care early in standard care for end-stage COPD patients.

Component 1: Training of the palliative home care team in care for end-stage COPD patients
Explanation of the componentBarriers and facilitators addressed by the component
Five nurses of the palliative home care team who will execute the intervention will follow a half-day training course on care for COPD patients. This is to prepare them for the intervention with COPD patients as the majority of those they currently support are cancer patients. A pulmonologist and a pulmonary physiotherapist/smoking cessation consultant from Ghent University hospital will give this part of the training. Another part will consist of learning to use the intervention tools (information leaflets and semi-structured protocol: see infra under component 3 and component 4) as the palliative home care nurses are not experienced in using them. This will be given by the executive researcher of the study, a sociologist from Ghent University.➢ No experience in clinical practice with palliative care for COPD (focus group—barrier)➢ Not enough focus on knowledge and advantages of palliative care for COPD in basic and continuing education (focus group- barrier)➢ More focus on early integration of PHC for COPD and concrete implementation in clinical practice in education for professional caregivers (focus group facilitator)➢ Training professional caregivers on early identification of patients in need of palliative care and structuring advance care planning (literature)
Component 2: monthly home visits by a palliative home care nurse
Explanation of the componentBarriers and facilitators addressed by the component
After the general practitioner has been brought into contact with the palliative home care nurse and the patient has been discharged at least two weeks from hospital (if the inclusion happened during hospitalisation), the patient will meet the palliative home care nurse during a first home visit where the palliative home care nurse will introduce himself/herself and explain what the palliative home care team can do for the patient during the intervention. Following this introductory visit, the palliative home care nurse will plan home visits at least once a month for a period of six months in total, the length of the study. If more adequate follow-up is needed, a higher frequency of visits will be given.➢ Specialised palliative care consultations integrated with standard care (literature)➢ Palliative status for palliative home care is based on predictability of death (focus group-barrier)➢ Palliative reimbursement of palliative home care is restricted to 3 months (focus group- barrier)➢ Not enough time during consultations to start talking about palliative care and further care (focus group–barrier)➢ Not discussing palliative care (needs) in detail during consultations with the end-stage COPD patient (focus group-barrier)➢ Professional caregivers fear talking about palliative home care because of the patient’s reaction (focus group-barrier)➢ Difficulties for professional caregivers to talk about palliative care needs with their end-stage COPD patients (focus group-barrier)
Component 3: Information leaflets
Explanation of the componentBarriers and facilitators addressed by the component
A palliative home care nurse will give, during one or more of the home visits, two information leaflets to the patient. The information leaflets have the goal to raise awareness and knowledge about COPD and to inform the patient on possible coping mechanisms. These information leaflets are Dutch-translated from the originally English leaflets and are part of the Canadian ‘Living well with COPD’ project, which is a learning method for patients and their families. Titles of the information leaflets are ‘Prevent and coping with complaints’ and ‘Breathing and saving energy’. The palliative home care nurse will explain the information leaflets during visit 1 and visit 2 (and in case of lack of time during visit 3) as good as possible to the patient and teach the patient how to use it. It is recommended to start with ‘Prevent and coping with complaints’ and then ‘breathing and saving energy’.➢ Educating patients with COPD (literature)➢ Self-management of patients with COPD (literature)➢ Not understanding the severity of the disease or realizing the possibility of death (focus group- barrier)➢ Denial of the severity of the disease (focus group- barrier)➢ Inform patients clearly and firmly about their disease and the future (focus group–facilitator)➢ Knowledge and disease insight (expert consultations)
Component 4: Semi-structured protocol during home visits
Explanation of the componentBarriers and facilitators addressed by the component
During each visit, the palliative home care nurse will use a semi-structured protocol to structure the visit and report about it (see Table 6). This semi-structured protocol will tackle the following areas: disease-insight and coping, symptom management, care planning, support for informal caregivers, psychosocial support (psychological, financial and administrative), spiritual support, other non-predefined support, an action plan and coordination of care. During every visit, the palliative home care nurse will fill in the semi-structured protocol, which will contain fill-in boxes for the nine focus areas, a box to note down actions and how many minutes of their visit were spent on each area. An action plan and a care plan will be included as well and will be updated during each visit.➢ Communication between caregiver and patient (focus group–barrier)    ◦ Not discussing palliative care (needs) in detail during consultations with the patient    ◦ Difficulties for professional caregivers to talk about end-of-life preferences and palliative care needs with patients    ◦ Patient-relative relationship can prevent communication about palliative care    ◦ Professional caregivers fear talking about palliative care because of the patient’s reaction➢ Increase knowledge about advantages of palliative home care for informal caregivers of patients with COPD (focus group–facilitator)➢ Start advance care planning as a standard procedure for all severe COPD patients living at home (FG—facilitator)➢ Communication between caregiver and the patient (focus group–facilitator)    ◦ Talking about practical matters can help the doctor start talking about palliative care    ◦ Better explanation of the term palliative home care can help acceptance by patient➢ Advance care planning as a part of palliative care (literature)➢ Self-management of patients with COPD (literature)➢ Advance care planning as a component of palliative care trials (expert consultations)➢ Psychosocial support (expert consultations)➢ Symptom control (expert consultations)➢ Involvement of those close to the patient (expert consultations)
Component 5: Integration of care between involved professional caregivers
Explanation of the componentBarriers and facilitators addressed by the component
The palliative home care team, responsible general practitioner, community nurse, physiotherapist and pulmonologist systematically receive, if the patient agrees, a report of every visit with a summary of the assessments and agreed actions. The palliative home care nurse sends this report directly to them through e-mail or post.The general practitioner(and if needed other relevant professional caregivers such as the community nurses) will be contacted by the palliative home care nurse to develop the care plan for the patient. If needed, any medical interventions by other professional caregivers can be coordinated together with the responsible general practitioner.➢ Lack of a coherent and proactive care plan (focus group barrier)    ◦ No cooperation between professional caregivers involved at home    ◦ Conflicting therapy and treatment between professional caregivers➢ Interprofessional communication (focus group barrier)    ◦ Not knowing each other well enough for proper communication    ◦ Unclear who takes initiative to introduce PHC to the patient    ◦ Not understanding each other’s messages➢ Communication between professional caregivers: appoint a care coordinator who facilitates the care transition to palliative home care (focus group–facilitator)

Discussion

Summary of the results

In this article we described the development and modelling of an intervention of early integrated palliative home care (PHC) for end-stage Chronic Obstructive Pulmonary Disease (COPD) patients. Predefined outcomes were improvement in quality of life for end-stage COPD patients and quality of care. Phase 0 resulted in the identification of possible inclusion criteria, components, barriers to and facilitators for early integration of PHC for end-stage COPD. Based on these findings, in Phase I, a nurse-led intervention was developed with inclusion criteria representing PHC needs and a decline in functioning. Five components were modelled: (1) Training on symptom recognition and physical therapy exercises for the involved PHC team; (2) Regular home visits by PHC nurses; (3) Two information leaflets on self-management of COPD; (4) A semi-structured protocol to record the outcomes of the PHC visits and (5) Integration of care by encouraging collaboration and communication between involved professional caregivers in primary and secondary care.

Strengths and weaknesses

A key strength was conducting a Phase 0–I study according to the Medical Research Council (MRC)-framework, as this provided a high-quality structured and phased process towards the development of a complex intervention[28]. This is confirmed by previous interventions on end-of-life care and advance care planning[6,27]. To our knowledge this is also the first nurse-led intervention exploring early integration of PHC for end-stage COPD, by combining several components with a holistic PHC approach. One limitation is that we did not directly consult the perspectives of end-stage COPD patients and their informal caregivers in Phase 0 whereas the primary focus was in fact to gain insight into care possibilities for early integration of PHC. The views of end-stage COPD patients on PHC have been captured in previous research[15], although without taking into account the specific Flemish context. However, interviews with half of the patients and informal caregivers from the intervention group will be conducted in the Phase II evaluation study, where their perspectives on the intervention components and on possible improvements for a Phase III intervention trial will be explored. Another limitation is that we did not included pulmonary rehabilitation as a separate component despite recommendations from expert consultations and literature, in the form of physical therapy sessions[34] or for breathlessness relief[6]. This was decided because pulmonary rehabilitation is formally not included in Flemish PHC services and the involved PHC nurses who will execute the intervention are not experienced with it. However, we included rehabilitation techniques and breathing exercises in the component ‘training for the PHC team’ and the PHC team will refer the patient to a pulmonary physiotherapist if needed. Furthermore, in the Phase II evaluation study, the necessity of incorporating it as a component in future interventions will be evaluated.

Comparison with existing literature

The component ‘semi-structured protocol’ was developed using combined elements from three previous interventions. The components of Weber et al[18] were used for shaping the content of the focus areas: symptom control, spiritual/existential, psychosocial and support for informal caregivers, knowledge about the disease and coordination of care. The components of Buckingham’s intervention[42] added a concrete self-management tool in the form of an action plan. From Vanbutsele’s et al [23] intervention we took the structure of the semi-structured protocol document, with indications of how long (in minutes) a PHC nurse will discuss one topic. This led to a semi-structured protocol which encompasses a complete care support programme. When comparing the intervention with study results in a recent review[5] about PC and symptom management for COPD, similarities and differences occurred. The review summarised current evidence on how symptoms and concerns in COPD could be addressed using PC interventions, and also deduced potential models for integrative working e.g. symptom-triggered services, short-term integrated PC, advanced COPD clinics and integrated respiratory care services (pulmonary rehabilitation, early supported discharge, hospital at home etc.). The findings indicated that these models could be triggered by indications for PC such as complex troublesome symptoms, a hospitalisation, change in place of residence, acute inpatient care for respiratory failure and the commencement of oxygen therapy. In the meantime, respiratory medicine and primary care could be offered simultaneously to the patient[5]. These suggested models focused mainly on managing specific symptoms such as breathlessness; which differed from the holistic focus of our intervention. A similarity is that the review supported early integration of PC with standard respiratory services. In our intervention pulmonologists will also receive monthly reports from the PHC nurse and will be able to co-decide, with the PHC nurse, about certain actions for the patient.

Implications for research, education and practice

Future research could focus on evaluating results of PHC interventions for end-stage COPD, and on analysing procedures and difficulties in enrolling and developing these interventions. Phase II interventions should also report more feasibility and acceptability results of participants, and could actively involve the latter in the development and evaluation phases. Currently, there is a lack of knowledge about all these aspects. Not only is the number of interventions on PHC for end-stage COPD low, published interventions also often fail to report study procedures, which impedes replication of interventions in other contexts. More reviews like Maddocks et al[5], that proved its usefulness for in-sight information about trials and studies about PC for end-stage COPD, could provide this lacking information. Furthermore, our results imply that more knowledge about care and support for end-stage COPD is needed for PHC nurses, but also for general practitioners (GPs) and community nurses. Emphasis on this topic should be provided in basic education with the possibility of learning skills in clinical practice. Further education on PHC should also include more disease specific support, for example learning breathing exercises for end-stage COPD, and should thus not be limited to care and support for cancer patients. In clinical practice for end-stage COPD, the roles of involved professional caregivers could be re-evaluated, by training PHC nurses better in providing pulmonary rehabilitation or teaching physiotherapists better in care for end-stage COPD. Early PHC for end-stage COPD, opposed to PHC given in the final stages of life or PHC for cancer, might also benefit from the involvement of pulmonary physiotherapists and psychologists besides PHC nurses.

Conclusion

This Phase 0-I process succeeded in developing a complex intervention for early integration of PHC into standard care for end-stage COPD patients. Three methods in Phase 0 gave reliable data with inclusion criteria and components for an intervention focused on holistic PHC. The feasibility, acceptability and preliminary effectiveness of the intervention will be subsequently tested in a Phase II study.

Topic guide expert consultations in English and in Dutch.

(DOCX) Click here for additional data file.

Key components of existing interventions and intervention protocols on palliative care and symptom management for end-stage COPD patients based on explorative literature search.

(DOCX) Click here for additional data file.

Explorative literature search on interventions and intervention protocols.

(DOCX) Click here for additional data file.

Overview of barriers and facilitators on inclusion criteria and components from the expert consultations.

(DOCX) Click here for additional data file.
  42 in total

1.  Developing a breathlessness intervention service for patients with palliative and supportive care needs, irrespective of diagnosis.

Authors:  Sara Booth; Catherine Moffat; Morag Farquhar; Irene J Higginson; Julie Burkin
Journal:  J Palliat Care       Date:  2011       Impact factor: 2.250

2.  Advance directives for seriously ill hospitalized patients: effectiveness with the patient self-determination act and the SUPPORT intervention. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.

Authors:  J Teno; J Lynn; N Wenger; R S Phillips; D P Murphy; A F Connors; N Desbiens; W Fulkerson; P Bellamy; W A Knaus
Journal:  J Am Geriatr Soc       Date:  1997-04       Impact factor: 5.562

3.  Home-based palliative care study: site of death, and costs of medical care for patients with congestive heart failure, chronic obstructive pulmonary disease, and cancer.

Authors:  Susan Milena Enguidanos; David Cherin; Richard Brumley
Journal:  J Soc Work End Life Palliat Care       Date:  2005

4.  Life quality of patients with chronic obstructive pulmonary disease.

Authors:  A J McSweeny; I Grant; R K Heaton; K M Adams; R M Timms
Journal:  Arch Intern Med       Date:  1982-03

5.  A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial.

Authors:  Vincent S Fan; J Michael Gaziano; Robert Lew; Jean Bourbeau; Sandra G Adams; Sarah Leatherman; Soe Soe Thwin; Grant D Huang; Richard Robbins; Peruvemba S Sriram; Amir Sharafkhaneh; M Jeffery Mador; George Sarosi; Ralph J Panos; Padmashri Rastogi; Todd H Wagner; Steven A Mazzuca; Colleen Shannon; Cindy Colling; Matthew H Liang; James K Stoller; Louis Fiore; Dennis E Niewoehner
Journal:  Ann Intern Med       Date:  2012-05-15       Impact factor: 25.391

6.  Training general practitioners in early identification and anticipatory palliative care planning: a randomized controlled trial.

Authors:  Bregje Thoonsen; Kris Vissers; S Verhagen; J Prins; H Bor; C van Weel; M Groot; Y Engels
Journal:  BMC Fam Pract       Date:  2015-09-22       Impact factor: 2.497

7.  Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol.

Authors:  Dorthe Gaby Bove; Dorthe Overgaard; Kirsten Lomborg; Bjarne Ørskov Lindhardt; Julie Midtgaard
Journal:  BMJ Open       Date:  2015-07-07       Impact factor: 2.692

8.  Efficacy of an educational intervention in primary health care in inhalation techniques: study protocol for a pragmatic cluster randomised controlled trial.

Authors:  José Leiva-Fernández; Rubén L Vázquez-Alarcón; Virginia Aguiar-Leiva; Mireya Lobnig-Becerra; Francisca Leiva-Fernández; Pilar Barnestein-Fonseca
Journal:  Trials       Date:  2016-03-17       Impact factor: 2.279

9.  The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial.

Authors:  Morag C Farquhar; A Toby Prevost; Paul McCrone; Barbara Brafman-Price; Allison Bentley; Irene J Higginson; Chris J Todd; Sara Booth
Journal:  Trials       Date:  2016-04-04       Impact factor: 2.279

10.  Effectiveness of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease in Taiwan-A Randomized Controlled Trial.

Authors:  Te-Wei Ho; Chun-Ta Huang; Herng-Chia Chiu; Sheng-Yuan Ruan; Yi-Ju Tsai; Chong-Jen Yu; Feipei Lai
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.